These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 24800694)
1. A modified method for implantation of pluripotent stem cells under the rodent kidney capsule. Zhu F; Sun B; Wen Y; Wang Z; Reijo Pera R; Chen B Stem Cells Dev; 2014 Sep; 23(17):2119-25. PubMed ID: 24800694 [TBL] [Abstract][Full Text] [Related]
2. Teratoma generation in the testis capsule. Peterson SE; Tran HT; Garitaonandia I; Han S; Nickey KS; Leonardo T; Laurent LC; Loring JF J Vis Exp; 2011 Nov; (57):e3177. PubMed ID: 22158256 [TBL] [Abstract][Full Text] [Related]
3. The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction. Neyrinck K; Breuls N; Holvoet B; Oosterlinck W; Wolfs E; Vanbilloen H; Gheysens O; Duelen R; Gsell W; Lambrichts I; Himmelreich U; Verfaillie CM; Sampaolesi M; Deroose CM Theranostics; 2018; 8(10):2799-2813. PubMed ID: 29774076 [No Abstract] [Full Text] [Related]
4. Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells. Matsu-ura T; Sasaki H; Okada M; Mikoshiba K; Ashraf M Stem Cell Res Ther; 2016 Feb; 7():30. PubMed ID: 26880084 [TBL] [Abstract][Full Text] [Related]
5. The teratoma assay: an in vivo assessment of pluripotency. Wesselschmidt RL Methods Mol Biol; 2011; 767():231-41. PubMed ID: 21822879 [TBL] [Abstract][Full Text] [Related]
6. Effects of cell number on teratoma formation by human embryonic stem cells. Lee AS; Tang C; Cao F; Xie X; van der Bogt K; Hwang A; Connolly AJ; Robbins RC; Wu JC Cell Cycle; 2009 Aug; 8(16):2608-12. PubMed ID: 19597339 [TBL] [Abstract][Full Text] [Related]
7. Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny. Gropp M; Shilo V; Vainer G; Gov M; Gil Y; Khaner H; Matzrafi L; Idelson M; Kopolovic J; Zak NB; Reubinoff BE PLoS One; 2012; 7(9):e45532. PubMed ID: 23049812 [TBL] [Abstract][Full Text] [Related]
9. Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation. Su W; Zhou M; Zheng Y; Fan Y; Wang L; Han Z; Kong D; Zhao RC; Wu JC; Xiang R; Li Z J Cell Biochem; 2011 Mar; 112(3):840-8. PubMed ID: 21328457 [TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells. Choi KA; Park HK; Hwang I; Jeong H; Park HS; Jang AY; Namkung Y; Hyun D; Lee S; Yoo BM; Kwon HJ; Seol KC; Kim JO; Hong S Stem Cells; 2020 Apr; 38(4):516-529. PubMed ID: 31778275 [TBL] [Abstract][Full Text] [Related]
11. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. Chung S; Shin BS; Hedlund E; Pruszak J; Ferree A; Kang UJ; Isacson O; Kim KS J Neurochem; 2006 Jun; 97(5):1467-80. PubMed ID: 16696855 [TBL] [Abstract][Full Text] [Related]
12. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Prokhorova TA; Harkness LM; Frandsen U; Ditzel N; Schrøder HD; Burns JS; Kassem M Stem Cells Dev; 2009; 18(1):47-54. PubMed ID: 18393673 [TBL] [Abstract][Full Text] [Related]
13. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice. Kishi Y; Tanaka Y; Shibata H; Nakamura S; Takeuchi K; Masuda S; Ikeda T; Muramatsu S; Hanazono Y Cell Transplant; 2008; 17(9):1095-102. PubMed ID: 19177845 [TBL] [Abstract][Full Text] [Related]
14. Identification of genes involved in tumor-like properties of embryonic stem cells. Takahashi K; Ichisaka T; Yamanaka S Methods Mol Biol; 2006; 329():449-58. PubMed ID: 16846009 [TBL] [Abstract][Full Text] [Related]
15. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Cao F; van der Bogt KE; Sadrzadeh A; Xie X; Sheikh AY; Wang H; Connolly AJ; Robbins RC; Wu JC Stem Cells Dev; 2007 Dec; 16(6):883-91. PubMed ID: 17896868 [TBL] [Abstract][Full Text] [Related]
16. In vivo tumor formation from primate embryonic stem cells. Asano T; Sasaki K; Kitano Y; Terao K; Hanazono Y Methods Mol Biol; 2006; 329():459-67. PubMed ID: 16846010 [TBL] [Abstract][Full Text] [Related]
17. Tumorigenesis in cells derived from induced pluripotent stem cells. Nishimori M; Yakushiji H; Mori M; Miyamoto T; Yaguchi T; Ohno S; Miyake Y; Sakaguchi T; Ueda M; Ohno E Hum Cell; 2014 Jan; 27(1):29-35. PubMed ID: 24122447 [TBL] [Abstract][Full Text] [Related]
18. STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation. Choi SW; Shin TH; Uddin MH; Shin JH; Kang TW; Lee BC; Kim HS; Seo Y; Shams S; Jung YK; Kang KS Oncotarget; 2016 Jan; 7(3):2684-95. PubMed ID: 26646796 [TBL] [Abstract][Full Text] [Related]